Get notified when UVSP files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsUnivest Financial Q2 EPS up 18.8% to $0.82; $28.6M loan on nonaccrual, $5.2M OREO write-down
Filed July 23, 2026 · Period ending July 22, 2026 · ~1 min read
Key Changes
-
high
Q2 2026 net income $23.0M ($0.82/share), up 18.8% YoY from $20.0M ($0.69/share), despite $5.2M pre-tax OREO write-down ($0.15/share impact) and $28.6M commercial loan placed on nonaccrual with $9.8M reserve.
Exhibit 99.1 view on EDGAR → -
high
Nonperforming assets rose to $63.0M at June 30, 2026 from $41.2M at March 31, 2026, driven by single $28.6M commercial loan relationship placed on nonaccrual with $9.8M specific reserve.
Exhibit 99.1 view on EDGAR → -
high
$5.2M pre-tax OREO valuation charge ($4.1M after-tax, $0.15/share) on property held since Q2 2022 and listed for sale since Q2 2025, based on updated appraisal reflecting fair value less costs to sell.
Exhibit 99.1 view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (INTC 10-Q) is open in full — no account needed.
Partner
Trade UVSP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 28, 2026 · How we verify